1-9 of 9
Li Xing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4480: Novel targeting API@API nanomedicines for synergistic molecular signaling modulation in head and neck cancer and the microenvironment

Free
Li-Xing Yang, Ru-Fen Chen, Yan-Wei Wu, Pei-Wen Wang, Chih-Chia Huang, Dar-Bin Shieh
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 4480.
https://doi.org/10.1158/1538-7445.AM2025-4480
Published: 21 April 2025
View articletitled, Abstract 4480: Novel targeting API@API nanomedicines for synergistic molecular signaling modulation in head and neck cancer and the microenvironment
Journal Articles

Abstract LB388: Super potent and efficacious ALK/ROS1/TRK inhibitor that overcomes multiple drug-resistant mutations

Free
Li Xing, Jingbing Wang, Wei Zhu
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB388.
https://doi.org/10.1158/1538-7445.AM2024-LB388
Published: 05 April 2024
View articletitled, Abstract LB388: Super potent and efficacious ALK/ROS1/TRK inhibitor that overcomes multiple drug-resistant mutations
Journal Articles

Abstract LB389: Highly potent and selective RET inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations

Free
Li Xing, Wei Zhu, Jingbing Wang
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB389.
https://doi.org/10.1158/1538-7445.AM2024-LB389
Published: 05 April 2024
View articletitled, Abstract LB389: Highly potent and selective RET inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations
Journal Articles

Abstract 1338: Discovery of novel, potent USP7 inhibitors that upregulate p53 leading to anti-proliferative effects in cancer cells

Free
Alan Futran, Tao Lu, Katherine Amberg-Johnson, Xiaoxiao Yang, Saidi He, Jeffrey Bell, Sarah Boyce, Markus Dahlgren, Karen Dingley, Liping Fang, Heidi Koldsoe, Zef Konst, Fang-Yu Lin, Robert Pelleltier, Heng Qian, Mats Svensson, Michael Trzoss, Jie Xu, Shuping Xu, Zhaowu Xu, Engin Yapici, Yan Zhang, Li Xing, Takao Suzuki, Xianhai Huang, Jiayi Xu, Hamish Wright, Kristian Jensen, Wayne Tang, Tao Guo, Karen Akinsanya, David Madge
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1338.
https://doi.org/10.1158/1538-7445.AM2021-1338
Published: 01 July 2021
View articletitled, Abstract 1338: Discovery of novel, potent USP7 inhibitors that upregulate p53 leading to anti-proliferative effects in cancer cells
Journal Articles

Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment

Free
John T. Isaacs, Lizamma Antony, Susan L. Dalrymple, W. Nathaniel Brennen, Stephanie Gerber, Hans Hammers, Michel Wissing, Sushant Kachhap, Jun Luo, Li Xing, Per Björk, Anders Olsson, Anders Björk, Tomas Leanderson
Journal: Cancer Research
Cancer Res (2013) 73 (4): 1386–1399.
https://doi.org/10.1158/0008-5472.CAN-12-2730
Published: 14 February 2013
View articletitled, Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
Open the PDF for Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment in another window
Includes: Supplementary data
Journal Articles

“OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo

Free
Kai Xiao, Yuanpei Li, Joyce S. Lee, Abby M. Gonik, Tiffany Dong, Gabriel Fung, Eduardo Sanchez, Li Xing, Holland R. Cheng, Juntao Luo, Kit S. Lam
Journal: Cancer Research
Cancer Res (2012) 72 (8): 2100–2110.
https://doi.org/10.1158/0008-5472.CAN-11-3883
Published: 16 April 2012
View articletitled, “OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo
Open the PDF for “OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo in another window
Includes: Supplementary data
Journal Articles

Abstract 5538: Enhanced tumor cytotoxicity of a combinational therapy using liposomal copper-doxorubicin, rapamycin, and ultrasound

Free
Azadeh Kheirolomoom, Lisa Mahakian, Chun-Yen Lai, Heather Lindfors, Jai Woong Seo, Katherine E. Watson, Eric Haynam, Elizabeth Ingham, Li Xing, Alexander D. Borowsky, Robert D. Cardiff, Katherine W. Ferrara
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5538.
https://doi.org/10.1158/1538-7445.AM10-5538
Published: 15 April 2010
View articletitled, Abstract 5538: Enhanced tumor cytotoxicity of a combinational therapy using liposomal copper-doxorubicin, rapamycin, and ultrasound
Journal Articles

Abstract 2643: A highly versatile nanoplatform for the treatment and imaging of cancers

Free
Kit S. Lam, Luo Juntao, Kai Xiao, Yuan-pei Li, Joyce Lee, Nianhuan Yao, Wenwu Xiao, Yabg Wang, Michael Kent, Holland Cheng, Li Xing, Gangyu Liu, Yihrong Tan
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2643.
https://doi.org/10.1158/1538-7445.AM10-2643
Published: 15 April 2010
View articletitled, Abstract 2643: A highly versatile nanoplatform for the treatment and imaging of cancers
Journal Articles

Abstract #3666: A novel class of targeted size-tunable therapeutic nanomicelles for the treatment and imaging of cancers

Free
Kit Lam, Juntao Luo, Kai Xiao, Yuan-pei Li, Joyce Lee, Nianhuan Yao, Wenwu Xiao, Yang Wang, Michael Kent, Holland Cheng, Li Xing, Gangyu Liu, Yihrong Tan
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3666.
Published: 01 May 2009
View articletitled, Abstract #3666: A novel class of targeted size-tunable therapeutic nanomicelles for the treatment and imaging of cancers